PERSONAL DATA: AGE: 71 years HEIGHT: 175 cm WEIGHT: 75 kg PSA TEST RESULTS: 12/04/2024 …… 4.2 ng/mL …… <4 ng/mL...
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Question asked:
PERSONAL DATA: AGE: 71 years HEIGHT: 175 cm WEIGHT: 75 kg PSA TEST RESULTS: [date removed] …… 4.2 ng/mL …… <4 ng/mL [date removed] …… 3.97 ng/mL …… <4 ng/mL [date removed] …… 4.11 ng/mL …… <4 ng/mL [date removed] …… 5.09 ng/mL …… <4 ng/mL [date removed] …… 5.14 ng/mL …… <4 ng/mL UROLOGIST VISIT: • I visited the urologist for the first time on Thursday, [date removed], for a prostate check-up. • Based on my age, my responses to his questionnaire, the ultrasound examination, and the digital rectal examination (negative), all findings were considered normal.
Your PSA Results: Educational Summary & Next Steps
Thank you for sharing your complete health information. Let me walk you through what your PSA pattern shows and what questions will help guide your care.
Your PSA Trend at a Glance
Your PSA values show a gradual upward drift over 3 months:
| Date | PSA Level | Status | |------|-----------|--------| | [date removed] | 4.2 ng/mL | Slightly elevated | | [date removed] | 3.97 ng/mL | ✓ Within range | | [date removed] | 4.11 ng/mL | Slightly elevated | | [date removed] | 5.09 ng/mL | ↑ Rising | | [date removed] | 5.14 ng/mL | ↑ Continuing to rise |
Key observation: Your PSA has climbed from ~4.0 to 5.14 ng/mL over the past 3 months—a 1.1 ng/mL increase in 3 months.
What This Means Educationally
PSA Basics
PSA (Prostate-Specific Antigen) is a protein your prostate produces. It's useful for monitoring, but it's not specific to cancer—many benign conditions raise PSA.
Your Specific Pattern
The reassuring aspects:
- ✅ Your May 2024 urologist exam was completely normal (digital rectal exam, ultrasound, questionnaire)
- ✅ Your PSA was stable for 5 months (April-September 2024)
- ✅ At age 71, modest PSA levels are common
- ✅ No cancer diagnosis has been made
The aspect requiring attention:
- ⚠️ Your recent upward trend (5.09 → 5.14 in one week, and 4.11 → 5.09 in 4.5 months) is worth investigating
- ⚠️ This rise crosses above the typical reference range of <4 ng/mL
Clinical Context (How Doctors Think About This)
According to NCCN Prostate Cancer Screening Guidelines and American Cancer Society recommendations, when PSA rises:
- Doctors consider the rate of change — A rise of 1+ ng/mL in 3 months is noticeable and warrants evaluation
- They look for benign explanations first:
- BPH (benign prostatic hyperplasia—enlarged prostate)
- Recent urinary tract infection or prostatitis
- Recent ejaculation or vigorous exercise
- Certain medications
- They repeat testing to confirm the trend is real (not a lab variation)
- They may order additional imaging if the trend continues
What Your Urologist Will Likely Consider
Given your rising PSA, your doctor will probably want to:
- Repeat PSA testing in 4-6 weeks to confirm this is a real trend
- Calculate PSA velocity (how fast it's changing over time)
- Review for benign causes — any recent infections, medications, or symptoms?
- Consider repeat ultrasound if the trend continues
- Discuss risk factors — family history, ethnicity, and other prostate cancer risk factors
Specific Questions to Ask Your Urologist
Since your PSA has risen noticeably, these questions will help you understand your situation:
-
"My PSA has risen from 4.1 to 5.14 in the last 3 months. What does this trend mean in my case?"
-
"Should we repeat the PSA test soon to confirm this is a real trend, or could this be a lab variation?"
-
"Given my normal exam findings last May, do you recommend any additional testing (repeat ultrasound, PSA velocity calculation, or other imaging)?"
-
"Are there any benign conditions that could explain this rise—like a recent infection or medication side effects?"
-
"What PSA level or rate of change would prompt you to recommend further investigation like a biopsy?"
-
"Based on my age, health, and this trend, what is your recommended monitoring schedule going forward?"
What the Medical Guidelines Say
According to NCCN Guidelines for Prostate Cancer Early Detection:
- PSA trends matter more than single values
- A PSA velocity (rate of rise) >0.75 ng/mL per year warrants closer evaluation
- Your recent rise (~1.1 ng/mL in 3 months = ~4.4 ng/mL per year) is above this threshold and should be monitored
According to the American Cancer Society:
- Men age 70+ should make individualized decisions about screening based on life expectancy and preferences
- Shared decision-making with your doctor is essential
Recommended Next Steps
✅ Schedule a follow-up appointment with your urologist to discuss this trend
✅ Get repeat PSA testing in 4-6 weeks (your doctor will advise timing)
✅ Bring a list of questions to your appointment
✅ Note any symptoms (urinary changes, pain, etc.) to discuss
✅ Ask about your individual risk factors for prostate cancer
Bottom Line
Your PSA rise is noticeable and worth investigating, but it's not automatically alarming. Your normal exam findings from May 2024 are reassuring. The next step is confirming whether this trend continues and exploring benign explanations with your urologist.
Your doctor will determine the appropriate next steps based on your complete clinical picture, including your age, life expectancy, preferences, and any additional testing results.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...
TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...
TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya
It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...
TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2